Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma

RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators

(2021) Alboukadel Kassambara et al.   LEUKEMIA

A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation

(2020) Xiao-Long Cui et al.   Nature Communications

The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation

(2019) Fabrice Chatonnet et al.   HAEMATOLOGICA

5‐Hydroxymethylcytosine as a clinical biomarker: Fluorescence‐based assay for high‐throughput epigenetic quantification in human tissues

(2019) Sapir Margalit et al.   INTERNATIONAL JOURNAL OF CANCER

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

(2018) Sikander Ailawadhi et al.   Blood Cancer Journal

The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA

(2015) Simona Segalla et al.   NUCLEIC ACIDS RESEARCH

PI3K-dependent multiple myeloma cell survival is mediated by the PIK3CA isoform

(2014) Claudia Hofmann et al.   BRITISH JOURNAL OF HAEMATOLOGY

FHL2 regulates hematopoietic stem cell functions under stress conditions

(2014) Y Hou et al.   LEUKEMIA

ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma

(2013) W Zhou et al.   LEUKEMIA

The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells

(2012) Chi-Hang Wong et al.   CYTOKINE

Structural diversity and African origin of the 17q21.31 inversion polymorphism

(2012) Karyn Meltz Steinberg et al.   NATURE GENETICS